权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Targeted TERS Investigations of Ligand-Receptor Binding

配体-受体结合的靶向 TERS 研究

基本信息

批准号：
9211336
负责人：
Zachary Schultz
金额：
$ 34.2万
依托单位：
UNIVERSITY OF NOTRE DAME
依托单位国家：
美国
项目类别：
财政年份：
2015
资助国家：
美国
起止时间：
2015-04-01 至 2020-01-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/9211336
关键词：
Accelerometer Address Adhesions Affinity Binding Biochemistry Cell membrane Cells Cellular Membrane Chemicals Comb animal structure Complex Coupling Data Detection Diffusion Disease Drug Targeting Environment Goals Gold Heterogeneity Immobilization In Situ In Vitro Individual Integrins Investigation Ligand Binding Ligands Location Measurement Membrane Membrane Proteins Metals Methodology Methods Molecular Monitor Nanostructures Peptides Pharmaceutical Preparations Pharmacologic Substance Property Proteins Receptor Signaling Reporting Research Resolution Role Signal Pathway Signal Transduction Specificity Spectrum Analysis Structure Surface Surface Plasmon Resonance System Techniques Technology Time Variant base experimental study imaging study improved insight instrumentation interest nanoparticle nanoscale new technology novel strategies particle plasmonics public health relevance receptor receptor binding spectroscopic survey tool trafficking

项目摘要

DESCRIPTION (provided by applicant): The goal of this proposal is to identify molecular interactions relevant to drug targeting and chemical signaling in cell membranes. More than half the drugs on the market target membrane proteins, a class of molecules where obtaining molecular detail in intact membranes challenges existing methods. We will use the plasmonic properties of nanoparticles to enable chemical-specific spectroscopic studies of ligand-receptor binding in intact cellular membranes. These investigations will demonstrate a new approach to probe the receptor's chemical residues that bind peptide antagonists and provide insight into molecular interactions that regulate the membrane proteins involved in signaling and drug targeting. Our approach combines tip enhanced Raman scattering (TERS), surface plasmon resonance (SPR) spectroscopy, and single particle tracking to characterize chemical interactions that regulate binding to membrane receptors. TERS will determine the chemical residues present in cell membranes that are associated with ligand binding. Initial results obtained in our lab indicate that ligand-functionalized nanoparticles selectively enhance the spectroscopic signals of the receptor involved in ligand binding. The ligand affinity can be determined from proteins immobilized on surfaces using SPR measurements. Complementary measurements can be performed in cells using single particle tracking. By taking advantage of technology that enables tracking of nanoparticles in real-time, we will characterize both ligand binding and membrane organization of individual ligand-functionalized nanoparticles bound to receptors on living cells. The specific aims of this proposal are: 1) Correlate in situ studies ligand affinity with the molecular identity of the receptor associated with peptide binding to the integrin receptors by combing TERS and SPR. 2) Explore protein receptor-binding interactions in vitro between integrin receptors and peptide ligands using targeted TERS. 3) Correlate in vitro binding affinity with chemical interaction by combining single nanoparticle tracking studies with TERS studies. The technology and platform we propose will address the challenge of obtaining chemical information from ligands binding to receptor proteins in intact cell membranes. These studies will provide new insights into the molecular interactions that regulate signaling pathways and how anomalies in these interactions are associated with disease and treatment.